S&P 500 Futures
(0.11%) 5 333.00 points

Dow Jones Futures
(0.05%) 40 159 points

Nasdaq Futures
(0.18%) 18 669 points

Oil
(-0.29%) $79.83

Gas
(1.10%) $2.66

Gold
(0.96%) $2 440.60

Silver
(2.63%) $32.08

Platinum
(0.17%) $1 091.80

USD/EUR
(0.01%) $0.920

USD/NOK
(-0.07%) $10.67

USD/GBP
(0.02%) $0.787

USD/RUB
(-0.62%) $90.41

Realtime updates for Dicerna Pharmaceuticals [DRNA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Last Updated31 Dec 1970 @ 19:00

25% discount on Stockinvest.us - Use code: Podcast

0.00% $ 38.22

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals...

Stats
Today's Volume	5.54M
Average Volume	3.03M
Market Cap	0.00
EPS	$-0.220 ( 2021-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.989 (2.59%)

Insider Trading

Date	Person	Action	Amount	type
2021-12-28	Koppel Adam	Sell	3 080 237	Common Stock
2021-12-28	Koppel Adam	Sell	3 333	Restricted Stock Units
2021-12-28	Koppel Adam	Sell	25 000	Director Stock Option (Right to Buy)
2021-12-28	Koppel Adam	Sell	25 000	Director Stock Option (Right to Buy)
2021-12-28	Koppel Adam	Sell	25 000	Director Stock Option (Right to Buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 12 087 \| Sell: 8 528 928

Volume Correlation

Long: 0.55 (weak)

Short: 0.93 (very strong)

Signal:(82.281) Expect same movement, but be aware

Dicerna Pharmaceuticals Correlation

10 Most Positive Correlations
ADMS	0.97
QADB	0.913
TYHT	0.901
DCRCU	0.898
FLXN	0.885
APOP	0.864
CNST	0.858
CNBKA	0.854
LCYAU	0.846
ICON	0.824

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dicerna Pharmaceuticals Correlation - Currency/Commodity

-0.39
( neutral )

0.13
( neutral )

-0.36
( neutral )

0.37
( neutral )

0.46
( neutral )

0.52
( weak )

Dicerna Pharmaceuticals Financials

Annual	2020
Revenue:	$164.31M
Gross Profit:	$164.31M (100.00 %)
EPS:	$-1.520

FY	2020
Revenue:	$164.31M
Gross Profit:	$164.31M (100.00 %)
EPS:	$-1.520

FY	2019
Revenue:	$23.90M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.760

FY	2018
Revenue:	$6.18M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.600

Financial Reports:

No articles found.

Dicerna Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Dicerna Pharmaceuticals

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare, cardiometabolic, viral, and chronic liver diseases; complement-mediated diseases; and neurodegenerative diseases and pain. Its principal development programs include nedosiran for the treatment of primary hyperoxaluria; RG6346 for the treatment of chronic hepatitis B virus infection; belcesiran for the treatment of deficiency-associated liver disease; and DCR-AUD for the treatment of alcohol use disorder. Dicerna Pharmaceuticals, Inc. has strategic collaborations with Novo Nordisk A/S, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., Eli Lilly and Company, Alnylam Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., and Boehringer Ingelheim International GmbH. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of December 27, 2021, Dicerna Pharmaceuticals, Inc. operates as a subsidiary of Novo Nordisk A/S.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.